TLPH (Talphera, Inc.) Stock Financials & Earnings | Market Cap Arena

TLPH (Talphera, Inc.) Stock Financials & Earnings | Market Cap Arena

TLPHTalphera, Inc.

Mkt Cap$18M

Healthcare·Drug Manufacturers - Specialty & Generic·🇺🇸 United States·NASDAQ

Revenue (TTM)$28,000

Net Income (TTM)-$12M

EPS (TTM)-$0.38

Free Cash Flow (TTM)-$11M

Gross Margin-8800.0%

Op. Margin-46525.0%

Net Margin-44242.9%

FCF Margin-39935.7%

P/S Ratio (TTM)649.7x

P/E Ratio (TTM)—

YoY Rev Growth-90.0%

Employees—

Earnings Reports

Next: Q4 2025 · Mar 16

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q4 22	$252K	-$110K	-$7M
Q1 23	$0	-$1M	-$5M
Q2 23	$253K	-$1M	-$4M
Q3 23	$117K	-$1M	-$3M
Q4 23	$281K	-$1M	-$4M
Q1 24	$0	-$1M	-$4M
Q2 24	$0	-$2M	-$4M
Q3 24	$0	-$2M	-$4M
Q4 24	$0	-$1M	-$3M
Q1 25	$27K	-$1M	-$3M
Q2 25	$0	$0	-$4M
Q3 25	$1K	$1K	-$3M

Valuation

Quarter	P/S	P/E
Q4 22	22.1x	0.4x
Q1 23	22.1x	0.4x
Q2 23	36.0x	—
Q3 23	29.2x	—
Q4 23	27.9x	—
Q1 24	27.9x	—
Q2 24	45.7x	—
Q3 24	64.7x	—
Q4 24	—	—
Q1 25	673.8x	—
Q2 25	673.8x	—
Q3 25	649.7x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 22	-$5M	-$5M
Q1 23	-$5M	-$5M
Q2 23	-$5M	-$5M
Q3 23	-$3M	-$3M
Q4 23	-$4M	-$4M
Q1 24	-$3M	-$3M
Q2 24	-$5M	-$5M
Q3 24	-$3M	-$3M
Q4 24	-$2M	-$2M
Q1 25	-$3M	-$3M
Q2 25	-$3M	-$3M
Q3 25	-$3M	-$3M

Capital Expenditures

CapEx

Quarter	CapEx
Q4 22	$48K
Q1 23	$100K
Q2 23	$0
Q3 23	$0
Q4 23	$0
Q1 24	$0
Q2 24	$0
Q3 24	$0
Q4 24	$0
Q1 25	$0
Q2 25	$0
Q3 25	$0

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 22	+12500.0%	-6.6%
Q1 23	—	+7.9%
Q2 23	-55.6%	-54.3%
Q3 23	—	-24.3%
Q4 23	+11.5%	-40.2%
Q1 24	—	-20.5%
Q2 24	-100.0%	+1.1%
Q3 24	-100.0%	+9.4%
Q4 24	-100.0%	-34.4%
Q1 25	—	-30.5%
Q2 25	—	-13.5%
Q3 25	—	-8.7%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 22	$628K	249.2%
Q1 23	$569K	—
Q2 23	$471K	186.2%
Q3 23	$0	0.0%
Q4 23	$311K	110.7%
Q1 24	$302K	—
Q2 24	$223K	—
Q3 24	$234K	—
Q4 24	$230K	—
Q1 25	$196K	725.9%
Q2 25	$166K	—
Q3 25	$152K	15200.0%

OpEx Breakdown

Quarter	R&D	SG&A
Q4 22	$1M	$6M
Q1 23	$1M	—
Q2 23	$2M	—
Q3 23	$1M	—
Q4 23	$2M	—
Q1 24	$1M	—
Q2 24	$2M	—
Q3 24	$2M	—
Q4 24	$1M	—
Q1 25	$1M	—
Q2 25	$2M	$2M
Q3 25	$2M	$2M

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 22	$15M	$495K	$16M
Q1 23	$13M	$0	$13M
Q2 23	$7M	$0	$7M
Q3 23	$13M	$0	$13M
Q4 23	$6M	$4M	$9M
Q1 24	$12M	$6M	$19M
Q2 24	$13M	$600K	$14M
Q3 24	$11M	$0	$11M
Q4 24	$9M	$0	$9M
Q1 25	$5M	$0	$5M
Q2 25	$7M	$0	$7M
Q3 25	$3M	$18M	$21M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q4 22	7M	+1.2%
Q1 23	11M	+45.9%
Q2 23	11M	+0.3%
Q3 23	17M	+53.4%
Q4 23	18M	+9.6%
Q1 24	25M	+34.6%
Q2 24	26M	+6.0%
Q3 24	26M	+0.0%
Q4 24	26M	+0.1%
Q1 25	26M	+0.1%
Q2 25	35M	+31.5%
Q3 25	41M	+20.0%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 13	—	—
FY 14	—	—
FY 15	—	—
FY 16	—	—
FY 17	—	—
FY 18	—	—
FY 19	—	—
FY 20	—	—
FY 21	—	—
FY 22	—	—
FY 23	—	—
FY 24	$0	13